Deep Intelligent Pharma (DIP) unveils a multi-agent Generative AI system for the entire clinical trial lifecycle. Building on AI protocol design, it designs optimized protocols and performs end-to-end "dry runs" using synthetic data, generating all trial documentation and identifying risks proactively. In live trials, AI agents automate data collection, analysis, and reporting, accelerating processes and ensuring extraordinay efficiency and data integrity from start to finish.